270 related articles for article (PubMed ID: 9773019)
21. Review: An update on inflammatory and autoimmune myopathies.
Dalakas MC
Neuropathol Appl Neurobiol; 2011 Apr; 37(3):226-42. PubMed ID: 21155862
[TBL] [Abstract][Full Text] [Related]
22. mTOR is expressed in polymyositis but not in sporadic inclusion body myositis.
Panaite PA; Stalder AK; Ipsen S; Kuntzer T; Steck AJ
Clin Neuropathol; 2015; 34(6):371-3. PubMed ID: 26104108
[No Abstract] [Full Text] [Related]
23. [Recent topics on inflammatory myositis].
Hase A; Orimo S; Arahata K
Nihon Naika Gakkai Zasshi; 1996 Jan; 85(1):123-8. PubMed ID: 8871321
[No Abstract] [Full Text] [Related]
24. [Inflammatory muscle diseases: dermatomyositis, polymyositis, and inclusion body myositis].
Genth E
Internist (Berl); 2005 Nov; 46(11):1218-32. PubMed ID: 16200404
[TBL] [Abstract][Full Text] [Related]
25. Unicorns, dragons, polymyositis, and other mythological beasts.
Amato AA; Griggs RC
Neurology; 2003 Aug; 61(3):288-9. PubMed ID: 12913184
[No Abstract] [Full Text] [Related]
26. Inflammatory myopathies.
Cherin P
Acta Clin Belg; 2004; 59(5):290-9. PubMed ID: 15641400
[No Abstract] [Full Text] [Related]
27. Magnetic resonance imaging criteria to differentiate inclusion body myositis from polymyositis.
Hengstman GJ
J Rheumatol; 2003 Aug; 30(8):1892. PubMed ID: 12913890
[No Abstract] [Full Text] [Related]
28. The three groups of polymyositis.
Serratrice G
Rev Rhum Engl Ed; 1996 Dec; 63(11):797-800. PubMed ID: 9010966
[No Abstract] [Full Text] [Related]
29. Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI).
Rider LG; Werth VP; Huber AM; Alexanderson H; Rao AP; Ruperto N; Herbelin L; Barohn R; Isenberg D; Miller FW
Arthritis Care Res (Hoboken); 2011 Nov; 63 Suppl 11(0 11):S118-57. PubMed ID: 22588740
[No Abstract] [Full Text] [Related]
30. Therapeutic options in autoimmune inflammatory myopathies (dermatomyositis, polymyositis, inclusion body myositis).
Pongratz D
J Neurol; 2006 Sep; 253 Suppl 5():V64-5. PubMed ID: 16998756
[TBL] [Abstract][Full Text] [Related]
31. [Myositis and the skin: cutaneous manifestations of dermatomyositis].
Jinnin M
Brain Nerve; 2013 Nov; 65(11):1283-90. PubMed ID: 24200606
[TBL] [Abstract][Full Text] [Related]
32. Update on idiopathic inflammatory myopathies.
Briani C; Doria A; Sarzi-Puttini P; Dalakas MC
Autoimmunity; 2006 May; 39(3):161-70. PubMed ID: 16769649
[TBL] [Abstract][Full Text] [Related]
33. Type 1 interferons and myositis.
Greenberg SA
Arthritis Res Ther; 2010; 12 Suppl 1(Suppl 1):S4. PubMed ID: 20392291
[TBL] [Abstract][Full Text] [Related]
34. Animal models in myositis.
Katsumata Y; Ascherman DP
Curr Opin Rheumatol; 2008 Nov; 20(6):681-5. PubMed ID: 18946328
[TBL] [Abstract][Full Text] [Related]
35. New Autoantibodies in Inflammatory Myopathies: Diagnostic Value and Relationship with Clinical Phenotypes.
Selva-O'Callaghan A; Cervera R
Isr Med Assoc J; 2015 Feb; 17(2):108-9. PubMed ID: 26223087
[No Abstract] [Full Text] [Related]
36. [Inflammatory myopathies from neurologist's perspective].
Pongratz D
Internist (Berl); 2000 May; 41(5):439-44. PubMed ID: 10867899
[No Abstract] [Full Text] [Related]
37. Plasma cells in muscle in inclusion body myositis and polymyositis.
Greenberg SA; Bradshaw EM; Pinkus JL; Pinkus GS; Burleson T; Due B; Bregoli L; O'Connor KC; Amato AA
Neurology; 2005 Dec; 65(11):1782-7. PubMed ID: 16344523
[TBL] [Abstract][Full Text] [Related]
38. Inflammatory myopathies [polymyositis, dermatomyositis, inclusion body myositis].
Bertorini TE
Compr Ther; 1998 Oct; 24(10):494-502. PubMed ID: 9801848
[TBL] [Abstract][Full Text] [Related]
39. Current diagnosis and treatment of polymyositis and dermatomyositis.
Sasaki H; Kohsaka H
Mod Rheumatol; 2018 Nov; 28(6):913-921. PubMed ID: 29669460
[TBL] [Abstract][Full Text] [Related]
40. Polymyositis and dermatomyositis.
Arthritis Rheum; 1970; 13(5):548-50. PubMed ID: 4921528
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
